Open AccessAn Overview: Antibiotic Sensitive Pattern in Urinary Tract Infection
Author(s) -
Reenoo Jauhari,
Manvi Bhatt,
Preeti Dudeja
Publication year - 2022
Publication title -
international journal of pharmaceutical sciences review and research
Language(s) - English
Resource type - Journals
ISSN - 0976-044X
DOI - 10.47583/ijpsrr.2022.v72i01.016
Subject(s) - staphylococcus saprophyticus , urinary system , proteus mirabilis , pyuria , medicine , antimicrobial , antibiotics , antibiotic resistance , enterobacter , trimethoprim , etiology , microbiology and biotechnology , staphylococcus aureus , biology , bacteria , staphylococcus , escherichia coli , biochemistry , gene , genetics
Urinary tract infections (UTIs) are the inflammatory disorders of the urinary tract caused by the abnormal growth of pathogens.Urinary tract infections can be community acquired or nosocomial. Symptoms of UTIs such as fever, burning sensations whileurinating, LAP, itching, formation of blisters and ulcers in the genital area, genital and supra pubic pain, and pyuria generally dependon the age of the person infected the location of the urinary tract infected. E.coli is the major etiologic agent in causing UTI, whichaccounts for up to 75%-90% of cases whereas Staphylococcus saprophyticus causes an estimated 5 - 1 5% of UTIs frequently inyounger women. P. mirabilis, Klebsiella species, P. aeruginosa and Enterobacter species are less frequent offenders. Less commonly,Enterococci, G. vaginalis and U. urealyticum are also known agents in UTIs. Due to the rapidly evolving adaptive strategies of bacteria,the etiology of UTI and antibiotic resistance profile of bacterial uropathogens have changed considerably over the past years, both incommunity and nosocomial infections. Treatment of UTIs cases is often started empirically and therapy is based on informationdetermined from the antimicrobial resistance pattern of the urinary pathogens.